Güzelöz Zeliha, Gök Balcı Umut
Radiation Oncology Department, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, TUR.
Palliative Care Clinic, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, TUR.
Cureus. 2023 Oct 2;15(10):e46351. doi: 10.7759/cureus.46351. eCollection 2023 Oct.
Introduction and objective Frailty is characterized by the body's increased susceptibility to stressors due to aging and a concurrent decline in its resilience. A dominant hypothesis suggests that oncological interventions may amplify this vulnerability. Consequently, elderly individuals with cancer may pose challenges for conventional treatments. This research sought to assess the effects of radiotherapy (RT) on the frailty of elderly cancer patients by utilizing the Edmonton Frail Scale (EFS). Methods This research was designed as a prospective observational study. Patients aged 65 and older, receiving treatment at the radiation oncology clinic, were asked to complete the EFS form both before and at the end of their RT course. The scores achieved before and after the RT were obtained, and the medical histories of the patients were recorded. The difference between the pre- and post-RT scores was calculated by subtracting the post-RT score from the pre-RT score to determine any increase or decrease in the score. For the statistical evaluations, a suite of tests (including the Shapiro-Wilk test, Kolmogorov-Smirnov test, paired sample t-test, independent t-tests, analysis of variance {ANOVA}, and Pearson correlation) were implemented. All analyses were conducted using the Statistical Package for Social Sciences (SPSS) software (version 29.0) (IBM SPSS Statistics, Armonk, NY). Results From April 2021 to August 2023, a total of 121 patients participated in the study. Out of these, 81 underwent assessments both pre- and post-RT. The median age was 73; the median follow-up period was five months. The predominant diagnoses included prostate cancer, breast cancer, and gynecological malignancies. A significant proportion of patients was diagnosed with stage IV cancer and underwent palliative RT. Post-RT evaluations revealed a decline in scores for some patients, while an increase was observed for others. Certain score variations were statistically significant. Moreover, an inverse correlation was discerned between the RT dose and fraction number and the post-RT EFS score. Conclusion Our research confirmed that a substantial number of patients either experienced a decrease or maintained stability in their EFS scores after RT. This observation suggests that RT might not exacerbate frailty in the elderly in the short term. Nevertheless, to elucidate the long-term impact of RT on frailty, there is a pressing need for a comprehensive assessment correlating EFS scores with survival rates.
引言与目的
衰弱的特征是由于衰老导致身体对应激源的易感性增加,同时恢复力下降。一个主流假说是肿瘤干预可能会加剧这种脆弱性。因此,老年癌症患者可能给传统治疗带来挑战。本研究旨在通过使用埃德蒙顿衰弱量表(EFS)评估放疗(RT)对老年癌症患者衰弱的影响。
方法
本研究设计为前瞻性观察性研究。年龄在65岁及以上、在放射肿瘤诊所接受治疗的患者被要求在放疗疗程开始前和结束时填写EFS表格。获取放疗前后的得分,并记录患者的病史。通过用放疗前得分减去放疗后得分来计算放疗前后得分的差异,以确定得分的增减情况。对于统计评估,实施了一系列测试(包括夏皮罗-威尔克检验、柯尔莫哥洛夫-斯米尔诺夫检验、配对样本t检验、独立t检验、方差分析{ANOVA}和皮尔逊相关性分析)。所有分析均使用社会科学统计软件包(SPSS)软件(版本29.0)(IBM SPSS Statistics,纽约州阿蒙克)进行。
结果
2021年4月至2023年8月,共有121名患者参与研究。其中,81名患者在放疗前后均接受了评估。中位年龄为73岁;中位随访期为5个月。主要诊断包括前列腺癌、乳腺癌和妇科恶性肿瘤。相当一部分患者被诊断为IV期癌症并接受了姑息性放疗。放疗后评估显示,一些患者的得分下降,而另一些患者得分上升。某些得分变化具有统计学意义。此外,放疗剂量和分次次数与放疗后EFS得分之间存在负相关。
结论
我们的研究证实,相当数量的患者在放疗后EFS得分要么下降,要么保持稳定。这一观察结果表明,放疗在短期内可能不会加剧老年人的衰弱。然而,为了阐明放疗对衰弱的长期影响,迫切需要进行一项将EFS得分与生存率相关联的综合评估。